COYA Earnings & Financial Statements
Coya Therapeutics, Inc.
$4.18
-$0.29(-6.59%)
51
Overall
60
Value
41
Tech
52
Quality
Market Cap
$98.05M
Volume
258.00K
52W Range
$3.71 - $7.75
Target Price
$15.19
COYA earnings and financial statements: Coya Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
COYA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.95M | $3.55M | $6.00M | - |
| Operating income | -$22.56M | -$17.25M | -$7.90M | -$9.81M |
| EBITDA | -$21.20M | -$15.57M | -$7.24M | -$9.26M |
| Net income | -$21.23M | -$14.88M | -$7.99M | -$12.24M |
| EPS (diluted) | $-1.27 | $-0.98 | $-0.79 | $-4.73 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $49.95M | $44.35M | $41.26M | $8.40M |
| Total liabilities | $6.92M | $4.77M | $5.63M | $16.79M |
| Shareholders’ equity | $43.03M | $39.58M | $35.64M | -$8.39M |
| Cash and equivalents | $46.80M | $38.34M | $32.63M | $5.93M |
| Long-term debt | - | - | - | $12.97M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$10.74M | -$10.29M | -$11.19M | -$7.24M |
| Free cash flow | -$10.74M | -$10.29M | -$11.19M | -$7.24M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | COYA | $4.18 | -6.6% | 258.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |